Toll Free: +1-855-465-4651 |  sales@marketnreports.com

Find Top Market Research Reports here

Home  >>   Pharmaceuticals & Healthcare  >>   Reports   >>  

Global Infantile Spasms Therapeutics Market 2018 - Industry Analysis, Production, Share, Growth, Sales, Trends, Supply, Forecast to 2025

 Published Date : Nov-2018   |    Format :PDF   |    Number of Pages : 119
This report studies the global market size of Infantile Spasms Therapeutics in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Infantile Spasms Therapeutics in these regions.
This research report categorizes the global Infantile Spasms Therapeutics market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

An infantile spasm (IS), also known as West Syndrome, is a specific type of seizure seen in an epilepsy syndrome of infancy and childhood. West Syndrome is characterized by infantile spasms, developmental regression, and a specific pattern on electroencephalography (EEG) testing called hypsarrhythmia (chaotic brain waves). The onset of infantile spasms is usually in the first year of life, typically between 4-8 months. The seizures primarily consist of a sudden bending forward of the body with stiffening of the arms and legs; some children arch their backs as they extend their arms and legs. The condition is usually observed in 2% of childhood epilepsies and 25% of epilepsies that start in the first year of life.
The global infantile spasms therapeutics market is growing at a slow pace. This is due to the increased availability of generic drugs and less approved therapies in the market and the less awareness of the disease and the available treatment options, especially in the low- and middle-income countries.
The classification of Infantile Spasms Therapeutics includes Oral, Injection. The proportion of Injection in 2016 is about 45%, and the proportion of Oral in 2016 is about 55%.
Based on application, the nitinol medical devices market is segmented into Hospital, Clinic and others. Clinic segment accounted for larger market share in terms of sales in 2016, Clinic segmented accounted for more than 45% of the market share in 2016.
United States is the largest consumption place, with a consumption market share nearly 83% in 2016. Following United States, Europe is the second largest consumption place with the consumption market share of 12.6% in 2016.
The US market is dominated by two approved products H.P. Acthar Gel (adrenocorticotropin hormone) and Sabril (vigabatrin). Sabril was the first drug to be approved by the Food and Drug Administration (FDA) in 2009 and H.P. Acthar Gel (adrenocorticotropin hormone) was approved for infantile spasms in 2010. Both have Orphan Drug Exclusivity (ODE) in the US.
In the future, the Infantile Spasms Therapeutics will have a good future; the price fluctuation has relationship with the raw material. The technology will more mature and the industry is more dispersion.
In 2017, the global Infantile Spasms Therapeutics market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Infantile Spasms Therapeutics market based on company, product type, application and key regions.

The various contributors involved in the value chain of Infantile Spasms Therapeutics include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Infantile Spasms Therapeutics include
    Mallinckrodt
    H. Lundbeck
    Insys Therapeutics
    Orphelia Pharma
    Valerion Therapeutics
    Catalyst Pharmaceuticals
    Anavex Life Sciences
    Retrophin
    GW Pharmaceuticals

Market Size Split by Type
    Oral
    Injection
Market Size Split by Application
    Hospital
    Clinic
    Other

Market size split by Region
    North America
        United States
        Canada
        Mexico
    Asia-Pacific
        China
        India
        Japan
        South Korea
        Australia
        Indonesia
        Singapore
        Malaysia
        Philippines
        Thailand
        Vietnam
    Europe
        Germany
        France
        UK
        Italy
        Spain
        Russia
    Central & South America
        Brazil
        Rest of Central & South America
    Middle East & Africa
        GCC Countries
        Turkey
        Egypt
        South Africa

The study objectives of this report are:
    To study and analyze the global Infantile Spasms Therapeutics market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
    To understand the structure of Infantile Spasms Therapeutics market by identifying its various subsegments.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    Focuses on the key global Infantile Spasms Therapeutics manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
    To analyze the Infantile Spasms Therapeutics with respect to individual growth trends, future prospects, and their contribution to the total market.
    To project the value and volume of Infantile Spasms Therapeutics submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Infantile Spasms Therapeutics are as follows:
    History Year: 2013-2017
    Base Year: 2017
    Estimated Year: 2018
    Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Infantile Spasms Therapeutics market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

1 Study Coverage
    1.1  Infantile Spasms Therapeutics Product
    1.2 Key Market Segments
    1.3 Key Manufacturers Covered
    1.4 Market by Type
        1.4.1 Global Infantile Spasms Therapeutics Market Size Growth Rate by Type
        1.4.2 Oral
        1.4.3 Injection
    1.5 Market by Application
        1.5.1 Global Infantile Spasms Therapeutics Market Size Growth Rate by Application
        1.5.2 Hospital
        1.5.3 Clinic
        1.5.4 Other
    1.6 Study Objectives
    1.7 Years Considered

2 Executive Summary
    2.1 Global Infantile Spasms Therapeutics Market Size
        2.1.1 Global Infantile Spasms Therapeutics Revenue 2016-2025
        2.1.2 Global Infantile Spasms Therapeutics Sales 2016-2025
    2.2 Infantile Spasms Therapeutics Growth Rate by Regions
        2.2.1 Global Infantile Spasms Therapeutics Sales by Regions
        2.2.2 Global Infantile Spasms Therapeutics Revenue by Regions

3 Breakdown Data by Manufacturers
    3.1 Infantile Spasms Therapeutics Sales by Manufacturers
        3.1.1 Infantile Spasms Therapeutics Sales by Manufacturers
        3.1.2 Infantile Spasms Therapeutics Sales Market Share by Manufacturers
        3.1.3 Global Infantile Spasms Therapeutics Market Concentration Ratio (CR5 and HHI)
    3.2 Infantile Spasms Therapeutics Revenue by Manufacturers
        3.2.1 Infantile Spasms Therapeutics Revenue by Manufacturers (2016-2018)
        3.2.2 Infantile Spasms Therapeutics Revenue Share by Manufacturers (2016-2018)
    3.3 Infantile Spasms Therapeutics Price by Manufacturers
    3.4 Infantile Spasms Therapeutics Manufacturing Base Distribution, Product Types
        3.4.1 Infantile Spasms Therapeutics Manufacturers Manufacturing Base Distribution, Headquarters
        3.4.2 Manufacturers Infantile Spasms Therapeutics Product Category
        3.4.3 Date of International Manufacturers Enter into Infantile Spasms Therapeutics  Market
    3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
    4.1 Global Infantile Spasms Therapeutics Sales by Type
    4.2 Global Infantile Spasms Therapeutics Revenue by Type
    4.3 Infantile Spasms Therapeutics Price by Type

5 Breakdown Data by Application
    5.1 Overview
    5.2 Global Infantile Spasms Therapeutics Breakdown Data by Application

6 North America
    6.1 North America Infantile Spasms Therapeutics by Countries
        6.1.1 North America Infantile Spasms Therapeutics Sales by Countries
        6.1.2 North America Infantile Spasms Therapeutics Revenue by Countries
        6.1.3 United States
        6.1.4 Canada
        6.1.5 Mexico
    6.2 North America Infantile Spasms Therapeutics by Type
    6.3 North America Infantile Spasms Therapeutics by Application
    6.4 North America Infantile Spasms Therapeutics by Company

7 Europe
    7.1 Europe Infantile Spasms Therapeutics by Countries
        7.1.1 Europe Infantile Spasms Therapeutics Sales by Countries
        7.1.2 Europe Infantile Spasms Therapeutics Revenue by Countries
        7.1.3 Germany
        7.1.4 France
        7.1.5 UK
        7.1.6 Italy
        7.1.7 Russia
    7.2 Europe Infantile Spasms Therapeutics by Type
    7.3 Europe Infantile Spasms Therapeutics by Application
    7.4 Europe Infantile Spasms Therapeutics by Company

8 Asia Pacific
    8.1 Asia Pacific Infantile Spasms Therapeutics by Countries
        8.1.1 Asia Pacific Infantile Spasms Therapeutics Sales by Countries
        8.1.2 Asia Pacific Infantile Spasms Therapeutics Revenue by Countries
        8.1.3 China
        8.1.4 Japan
        8.1.5 Korea
        8.1.6 India
        8.1.7 Australia
        8.1.8 Indonesia
        8.1.9 Malaysia
        8.1.10 Philippines
        8.1.11 Thailand
        8.1.12 Vietnam
        8.1.13 Singapore
    8.2 Asia Pacific Infantile Spasms Therapeutics by Type
    8.3 Asia Pacific Infantile Spasms Therapeutics by Application
    8.4 Asia Pacific Infantile Spasms Therapeutics by Company

9 Central & South America
    9.1 Central & South America Infantile Spasms Therapeutics by Countries
        9.1.1 Central & South America Infantile Spasms Therapeutics Sales by Countries
        9.1.2 Central & South America Infantile Spasms Therapeutics Revenue by Countries
        9.1.3 Brazil
    9.2 Central & South America Infantile Spasms Therapeutics by Type
    9.3 Central & South America Infantile Spasms Therapeutics by Application
    9.4 Central & South America Infantile Spasms Therapeutics by Company

10 Middle East and Africa
    10.1 Middle East and Africa Infantile Spasms Therapeutics by Countries
        10.1.1 Middle East and Africa Infantile Spasms Therapeutics Sales by Countries
        10.1.2 Middle East and Africa Infantile Spasms Therapeutics Revenue by Countries
        10.1.3 GCC Countries
        10.1.4 Turkey
        10.1.5 Egypt
        10.1.6 South Africa
    10.2 Middle East and Africa Infantile Spasms Therapeutics by Type
    10.3 Middle East and Africa Infantile Spasms Therapeutics by Application
    10.4 Middle East and Africa Infantile Spasms Therapeutics by Company

11 Company Profiles
    11.1 Mallinckrodt
        11.1.1 Mallinckrodt Company Details
        11.1.2 Company Description
        11.1.3 Sales, Revenue and Gross Margin of Infantile Spasms Therapeutics
        11.1.4 Infantile Spasms Therapeutics Product Description
        11.1.5 Recent Development
    11.2 H. Lundbeck
        11.2.1 H. Lundbeck Company Details
        11.2.2 Company Description
        11.2.3 Sales, Revenue and Gross Margin of Infantile Spasms Therapeutics
        11.2.4 Infantile Spasms Therapeutics Product Description
        11.2.5 Recent Development
    11.3 Insys Therapeutics
        11.3.1 Insys Therapeutics Company Details
        11.3.2 Company Description
        11.3.3 Sales, Revenue and Gross Margin of Infantile Spasms Therapeutics
        11.3.4 Infantile Spasms Therapeutics Product Description
        11.3.5 Recent Development
    11.4 Orphelia Pharma
        11.4.1 Orphelia Pharma Company Details
        11.4.2 Company Description
        11.4.3 Sales, Revenue and Gross Margin of Infantile Spasms Therapeutics
        11.4.4 Infantile Spasms Therapeutics Product Description
        11.4.5 Recent Development
    11.5 Valerion Therapeutics
        11.5.1 Valerion Therapeutics Company Details
        11.5.2 Company Description
        11.5.3 Sales, Revenue and Gross Margin of Infantile Spasms Therapeutics
        11.5.4 Infantile Spasms Therapeutics Product Description
        11.5.5 Recent Development
    11.6 Catalyst Pharmaceuticals
        11.6.1 Catalyst Pharmaceuticals Company Details
        11.6.2 Company Description
        11.6.3 Sales, Revenue and Gross Margin of Infantile Spasms Therapeutics
        11.6.4 Infantile Spasms Therapeutics Product Description
        11.6.5 Recent Development
    11.7 Anavex Life Sciences
        11.7.1 Anavex Life Sciences Company Details
        11.7.2 Company Description
        11.7.3 Sales, Revenue and Gross Margin of Infantile Spasms Therapeutics
        11.7.4 Infantile Spasms Therapeutics Product Description
        11.7.5 Recent Development
    11.8 Retrophin
        11.8.1 Retrophin Company Details
        11.8.2 Company Description
        11.8.3 Sales, Revenue and Gross Margin of Infantile Spasms Therapeutics
        11.8.4 Infantile Spasms Therapeutics Product Description
        11.8.5 Recent Development
    11.9 GW Pharmaceuticals
        11.9.1 GW Pharmaceuticals Company Details
        11.9.2 Company Description
        11.9.3 Sales, Revenue and Gross Margin of Infantile Spasms Therapeutics
        11.9.4 Infantile Spasms Therapeutics Product Description
        11.9.5 Recent Development

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
    12.1 Market Opportunities and Drivers
    12.2 Market Challenges
    12.3 Market Risks/Restraints
    12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
    13.1 Value Chain Analysis
        13.1.1 Typical Suppliers of Key Infantile Spasms Therapeutics Raw Material
        13.1.2 Infantile Spasms Therapeutics Customers
    13.2 Sales Channels Analysis
        13.2.1 Sales Channels Analysis
        13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
            15.1.1.1 Research Programs/Design
            15.1.1.2 Market Size Estimation
            15.1.1.3 Market Breakdown and Data Triangulation
        15.1.2 Data Source
            15.1.2.1 Secondary Sources
            15.1.2.2 Primary Sources
    15.2 Author Details
    15.3 Disclaimer



List of Tables and Figures

    Figure Picture of Infantile Spasms Therapeutics
    Figure Global Infantile Spasms Therapeutics Production (Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
    Figure Global Infantile Spasms Therapeutics Production Market Share by Types (Product Category) in 2017
    Figure Oral Product Picture
    Table Major Manufacturers of Oral
    Figure Injection Product Picture
    Table Major Manufacturers of Injection
    Table Global Infantile Spasms Therapeutics Market Size Growth Rate by Application 2018-2025 (Units)
    Figure Hospital
    Figure Clinic
    Figure Other
    Figure Infantile Spasms Therapeutics Report Years Considered
    Figure Global Infantile Spasms Therapeutics Market Size 2016-2025 (Million US$)
    Figure Global Infantile Spasms Therapeutics Sales 2016-2025 (Units)
    Table Global Infantile Spasms Therapeutics Market Size by Regions 2016-2025 (Units) & (Million US$)
    Table Global Infantile Spasms Therapeutics Sales by Regions 2016-2025 (Units)
    Table Global Infantile Spasms Therapeutics Sales Market Share by Regions 2016-2025
    Figure Global Infantile Spasms Therapeutics Sales Market Share by Regions 2016-2025
    Figure 2017 Global Infantile Spasms Therapeutics Sales Market Share by Regions
    Table Global Infantile Spasms Therapeutics Revenue by Regions 2016-2025 (Million US$)
    Table Global Infantile Spasms Therapeutics Revenue Market Share by Regions 2016-2025
    Figure Global Infantile Spasms Therapeutics Revenue Market Share by Regions 2016-2025
    Figure 2017 Global Infantile Spasms Therapeutics Revenue Market Share by Regions
    Table Global Infantile Spasms Therapeutics Sales by Manufacturers (2016-2018) (Units)
    Table Global Infantile Spasms Therapeutics Sales Share by Manufacturers (2016-2018)
    Figure Global Infantile Spasms Therapeutics Sales Share by Manufacturers in 2017
    Table Infantile Spasms Therapeutics Revenue by Manufacturers (2016-2018) (Million US$)
    Table Infantile Spasms Therapeutics Revenue Share by Manufacturers (2016-2018)
    Figure Infantile Spasms Therapeutics Value Share by Manufacturers in 2017
    Table Global Infantile Spasms Therapeutics Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table Key Manufacturers Infantile Spasms Therapeutics Price (2016-2018) (USD/Unit)
    Table Infantile Spasms Therapeutics Manufacturers Manufacturing Base Distribution and Headquarters
    Table Manufacturers Infantile Spasms Therapeutics Product Category
    Table Date of International Manufacturers Enter into Infantile Spasms Therapeutics Market
    Table Manufacturers Mergers & Acquisitions, Expansion Plans
    Table Global Infantile Spasms Therapeutics Sales by Type (2016-2025) (Units)
    Table Global Infantile Spasms Therapeutics Sales Share by Type (2016-2025)
    Figure Global Infantile Spasms Therapeutics Sales Market Share by Type (2016-2025)
    Figure Global Infantile Spasms Therapeutics Sales Market Share by Type in 2017
    Table Global Infantile Spasms Therapeutics Revenue by Type (2016-2025) (Million US$)
    Table Global Infantile Spasms Therapeutics Revenue Share by Type (2016-2025)
    Figure Global Infantile Spasms Therapeutics Revenue Market Share by Type (2016-2025)
    Figure Global Infantile Spasms Therapeutics Revenue Market Share by Type in 2017
    Table Infantile Spasms Therapeutics Price by Type 2013-2018 (USD/Unit)
    Table Global Infantile Spasms Therapeutics Sales by Application (2016-2025) (Units)
    Table Global Infantile Spasms Therapeutics Sales Share by Application (2016-2025)
    Figure Global Sales Infantile Spasms Therapeutics Market Share by Application (2016-2025)
    Figure Global Sales Infantile Spasms Therapeutics Market Share by Application (2016-2025)
    Figure North America Infantile Spasms Therapeutics Sales Growth Rate 2016-2025 (Units)
    Figure North America Infantile Spasms Therapeutics Revenue Growth Rate 2016-2025 (Million US$)
    Table North America Infantile Spasms Therapeutics Sales by Countries (2016-2025) (Units)
    Table North America Infantile Spasms Therapeutics Sales Market Share by Countries (2016-2025)
    Figure 2017 North America Infantile Spasms Therapeutics Sales Market Share by Countries
    Table North America Infantile Spasms Therapeutics Revenue by Countries (2016-2025) (Million US$)
    Table North America Infantile Spasms Therapeutics Revenue Market Share by Countries (2016-2025)
    Figure 2017 North America Infantile Spasms Therapeutics Revenue Market Share by Countries
    Figure United States Infantile Spasms Therapeutics Sales Growth Rate (2016-2025) (Units)
    Figure United States Infantile Spasms Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Canada Infantile Spasms Therapeutics Sales Growth Rate (2016-2025) (Units)
    Figure Canada Infantile Spasms Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Mexico Infantile Spasms Therapeutics Sales Growth Rate (2016-2025) (Units)
    Figure Mexico Infantile Spasms Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Table North America Infantile Spasms Therapeutics Sales by Type (2016-2025) (Units)
    Table North America Infantile Spasms Therapeutics Sales Market Share by Type (2016-2025)
    Figure 2017 North America Infantile Spasms Therapeutics Market Share by Type
    Table North America Infantile Spasms Therapeutics Sales by Application (2016-2025) (Units)
    Table North America Infantile Spasms Therapeutics Sales Market Share by Application (2016-2025)
    Figure 2017 North America Infantile Spasms Therapeutics Market Share by Application
    Table North America Infantile Spasms Therapeutics Sales by Company (2016-2018) (Units)
    Table North America Infantile Spasms Therapeutics Sales Market Share by Company (2016-2018)
    Figure North America Infantile Spasms Therapeutics Sales Market Share by Company in 2017
    Figure Europe Infantile Spasms Therapeutics Sales Growth Rate 2016-2025 (Units)
    Figure Europe Infantile Spasms Therapeutics Revenue Growth Rate 2016-2025 (Million US$)
    Table Europe Infantile Spasms Therapeutics Sales by Countries (2016-2025) (Units)
    Table Europe Infantile Spasms Therapeutics Sales Market Share by Countries (2016-2025)
    Figure 2017 Europe Infantile Spasms Therapeutics Sales Market Share by Countries
    Table Europe Infantile Spasms Therapeutics Revenue by Countries (2016-2025) (Million US$)
    Table Europe Infantile Spasms Therapeutics Revenue Market Share by Countries (2016-2025)
    Figure 2017 Europe Infantile Spasms Therapeutics Revenue Market Share by Countries
    Figure Germany Infantile Spasms Therapeutics Sales Growth Rate (2016-2025) (Units)
    Figure Germany Infantile Spasms Therapeutics Revenue Growth Rate (2016-2025) (Units)
    Figure France Infantile Spasms Therapeutics Sales Growth Rate (2016-2025) (Units)
    Figure France Infantile Spasms Therapeutics Revenue Growth Rate (2016-2025) (Units)
    Figure UK Infantile Spasms Therapeutics Sales Growth Rate (2016-2025) (Units)
    Figure UK Infantile Spasms Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Italy Infantile Spasms Therapeutics Sales Growth Rate (2016-2025) (Units)
    Figure Italy Infantile Spasms Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Russia Infantile Spasms Therapeutics Sales Growth Rate (2016-2025) (Units)
    Figure Russia Infantile Spasms Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Table Europe Infantile Spasms Therapeutics Sales by Type (2016-2025) (Units)
    Table Europe Infantile Spasms Therapeutics Sales Market Share by Type (2016-2025)
    Figure 2017 Europe Infantile Spasms Therapeutics Market Share by Type
    Table Europe Infantile Spasms Therapeutics Sales by Application (2016-2025) (Units)
    Table Europe Infantile Spasms Therapeutics Sales Market Share by Application (2016-2025)
    Figure 2017 Europe Infantile Spasms Therapeutics Market Share by Application
    Table Europe Infantile Spasms Therapeutics Sales by Company (2016-2018) (Units)
    Table Europe Infantile Spasms Therapeutics Sales Market Share by Company (2016-2018)
    Figure Europe Infantile Spasms Therapeutics Sales Market Share by Company in 2017
    Figure Asia Pacific Infantile Spasms Therapeutics Sales Growth Rate 2016-2025 (Units)
    Figure Asia Pacific Infantile Spasms Therapeutics Revenue Growth Rate 2016-2025 (Million US$)
    Table Asia Pacific Infantile Spasms Therapeutics Sales by Countries (2016-2025) (Units)
    Table Asia Pacific Infantile Spasms Therapeutics Sales Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Infantile Spasms Therapeutics Sales Market Share by Countries
    Table Asia Pacific Infantile Spasms Therapeutics Revenue by Countries (2016-2025) (Million US$)
    Table Asia Pacific Infantile Spasms Therapeutics Revenue Market Share by Countries (2016-2025)
    Figure 2017 Asia Pacific Infantile Spasms Therapeutics Revenue Market Share by Countries
    Figure China Infantile Spasms Therapeutics Sales Growth Rate (2016-2025) (Units)
    Figure China Infantile Spasms Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Japan Infantile Spasms Therapeutics Sales Growth Rate (2016-2025) (Units)
    Figure Japan Infantile Spasms Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Korea Infantile Spasms Therapeutics Sales Growth Rate (2016-2025) (Units)
    Figure Korea Infantile Spasms Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure India Infantile Spasms Therapeutics Sales Growth Rate (2016-2025) (Units)
    Figure India Infantile Spasms Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Australia Infantile Spasms Therapeutics Sales Growth Rate (2016-2025) (Units)
    Figure Australia Infantile Spasms Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Indonesia Infantile Spasms Therapeutics Sales Growth Rate (2016-2025) (Units)
    Figure Indonesia Infantile Spasms Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Malaysia Infantile Spasms Therapeutics Sales Growth Rate (2016-2025) (Units)
    Figure Malaysia Infantile Spasms Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Philippines Infantile Spasms Therapeutics Sales Growth Rate (2016-2025) (Units)
    Figure Philippines Infantile Spasms Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Thailand Infantile Spasms Therapeutics Sales Growth Rate (2016-2025) (Units)
    Figure Thailand Infantile Spasms Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Vietnam Infantile Spasms Therapeutics Sales Growth Rate (2016-2025) (Units)
    Figure Vietnam Infantile Spasms Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Singapore Infantile Spasms Therapeutics Sales Growth Rate (2016-2025) (Units)
    Figure Singapore Infantile Spasms Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Table Asia Pacific Infantile Spasms Therapeutics Sales by Type (2016-2025) (Units)
    Table Asia Pacific Infantile Spasms Therapeutics Sales Market Share by Type (2016-2025)
    Figure 2017 Asia Pacific Infantile Spasms Therapeutics Market Share by Type
    Table Asia Pacific Infantile Spasms Therapeutics Sales by Application (2016-2025) (Units)
    Table Asia Pacific Infantile Spasms Therapeutics Sales Market Share by Application (2016-2025)
    Figure 2017 Asia Pacific Infantile Spasms Therapeutics Market Share by Application
    Table Asia Pacific Infantile Spasms Therapeutics Sales by Company (2016-2018) (Units)
    Table Asia Pacific Infantile Spasms Therapeutics Sales Market Share by Company (2016-2018)
    Figure Asia Pacific Infantile Spasms Therapeutics Sales Market Share by Company in 2017
    Figure Central & South America Infantile Spasms Therapeutics Sales Growth Rate 2016-2025 (Units)
    Figure Central & South America Infantile Spasms Therapeutics Revenue Growth Rate 2016-2025 (Million US$)
    Table Central & South America Infantile Spasms Therapeutics Sales by Countries (2016-2025) (Units)
    Table Central & South America Infantile Spasms Therapeutics Sales Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Infantile Spasms Therapeutics Sales Market Share by Countries
    Table Central & South America Infantile Spasms Therapeutics Revenue by Countries (2016-2025) (Million US$)
    Table Central & South America Infantile Spasms Therapeutics Revenue Market Share by Countries (2016-2025)
    Figure 2017 Central & South America Infantile Spasms Therapeutics Revenue Market Share by Countries
    Figure Brazil Infantile Spasms Therapeutics Sales Growth Rate (2016-2025) (Units)
    Figure Brazil Infantile Spasms Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Argentina Infantile Spasms Therapeutics Sales Growth Rate (2016-2025) (Units)
    Figure Argentina Infantile Spasms Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Table Central & South America Infantile Spasms Therapeutics Sales by Type (2016-2025) (Units)
    Table Central & South America Infantile Spasms Therapeutics Sales Market Share by Type (2016-2025)
    Figure 2017 Central & South America Infantile Spasms Therapeutics Market Share by Type
    Table Central & South America Infantile Spasms Therapeutics Sales by Application (2016-2025) (Units)
    Table Central & South America Infantile Spasms Therapeutics Sales Market Share by Application (2016-2025)
    Figure 2017 Central & South America Infantile Spasms Therapeutics Market Share by Application
    Table Central & South America Infantile Spasms Therapeutics Sales by Company (2016-2018) (Units)
    Table Central & South America Infantile Spasms Therapeutics Sales Market Share by Company (2016-2018)
    Figure Central & South America Infantile Spasms Therapeutics Sales Market Share by Company in 2017
    Figure Middle East and Africa Infantile Spasms Therapeutics Sales Growth Rate 2016-2025 (Units)
    Figure Middle East and Africa Infantile Spasms Therapeutics Revenue Growth Rate 2016-2025 (Million US$)
    Table Middle East and Africa Infantile Spasms Therapeutics Sales by Countries (2016-2025) (Units)
    Table Middle East and Africa Infantile Spasms Therapeutics Sales Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Infantile Spasms Therapeutics Sales Market Share by Countries
    Table Middle East and Africa Infantile Spasms Therapeutics Revenue by Countries (2016-2025) (Million US$)
    Table Middle East and Africa Infantile Spasms Therapeutics Revenue Market Share by Countries (2016-2025)
    Figure 2017 Middle East and Africa Infantile Spasms Therapeutics Revenue Market Share by Countries
    Figure GCC Countries Infantile Spasms Therapeutics Sales Growth Rate (2016-2025) (Units)
    Figure GCC Countries Infantile Spasms Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Turkey Infantile Spasms Therapeutics Sales Growth Rate (2016-2025) (Units)
    Figure Turkey Infantile Spasms Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure Egypt Infantile Spasms Therapeutics Sales Growth Rate (2016-2025) (Units)
    Figure Egypt Infantile Spasms Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Figure South Africa Infantile Spasms Therapeutics Sales Growth Rate (2016-2025) (Units)
    Figure South Africa Infantile Spasms Therapeutics Revenue Growth Rate (2016-2025) (Million US$)
    Table Middle East and Africa Infantile Spasms Therapeutics Sales by Type (2016-2025) (Units)
    Table Middle East and Africa Infantile Spasms Therapeutics Sales Market Share by Type (2016-2025)
    Figure 2017 Middle East and Africa Infantile Spasms Therapeutics Market Share by Type
    Table Middle East and Africa Infantile Spasms Therapeutics Sales by Application (2016-2025) (Units)
    Table Middle East and Africa Infantile Spasms Therapeutics Sales Market Share by Application (2016-2025)
    Figure 2017 Middle East and Africa Infantile Spasms Therapeutics Market Share by Application
    Table Middle East and Africa Infantile Spasms Therapeutics Sales by Company (2016-2018) (Units)
    Table Middle East and Africa Infantile Spasms Therapeutics Sales Market Share by Company (2016-2018)
    Figure Middle East and Africa Infantile Spasms Therapeutics Sales Market Share by Company in 2017
    Table Mallinckrodt Company Details
    Table Mallinckrodt Infantile Spasms Therapeutics Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Mallinckrodt Recent Development
    Table H. Lundbeck Company Details
    Table H. Lundbeck Infantile Spasms Therapeutics Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table H. Lundbeck Recent Development
    Table Insys Therapeutics Company Details
    Table Insys Therapeutics Infantile Spasms Therapeutics Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Insys Therapeutics Recent Development
    Table Orphelia Pharma Company Details
    Table Orphelia Pharma Infantile Spasms Therapeutics Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Orphelia Pharma Recent Development
    Table Valerion Therapeutics Company Details
    Table Valerion Therapeutics Infantile Spasms Therapeutics Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Valerion Therapeutics Recent Development
    Table Catalyst Pharmaceuticals Company Details
    Table Catalyst Pharmaceuticals Infantile Spasms Therapeutics Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Catalyst Pharmaceuticals Recent Development
    Table Anavex Life Sciences Company Details
    Table Anavex Life Sciences Infantile Spasms Therapeutics Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Anavex Life Sciences Recent Development
    Table Retrophin Company Details
    Table Retrophin Infantile Spasms Therapeutics Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table Retrophin Recent Development
    Table GW Pharmaceuticals Company Details
    Table GW Pharmaceuticals Infantile Spasms Therapeutics Sales (Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
    Table GW Pharmaceuticals Recent Development
    Figure GDP by Regions / Largest Economies Pie Chart in 2016
    Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
    Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
    Figure Saving Rate Total, % of GDP, 2015
    Table Infantile Spasms Therapeutics Value Chain
    Table Typical Suppliers of Key Infantile Spasms Therapeutics Raw Material
    Table Infantile Spasms Therapeutics Customers List
    Table Infantile Spasms Therapeutics Sales Channels
    Table Infantile Spasms Therapeutics Distributors List
    Table Research Programs/Design for This Report
    Figure Bottom-up and Top-down Approaches for This Report
    Figure Data Triangulation
    Table Key Data Information from Secondary Sources
    Table Key Data Information from Primary Sources
Latest News
Read more